Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Oct;49(10):10137-10140.
doi: 10.1007/s11033-022-07493-z. Epub 2022 May 21.

Relevant of neutralizing antibody during SARS-CoV-2 infection and their therapeutic usage

Affiliations

Relevant of neutralizing antibody during SARS-CoV-2 infection and their therapeutic usage

Sneh Lata Gupta et al. Mol Biol Rep. 2022 Oct.
No abstract available

Keywords: Delta variant; Neutralizing antibodies; Omicron variant; Receptor binding domain (RBD); SARS-CoV-2.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflicts of interests.

Similar articles

Cited by

References

    1. Pang NY-L, et al. Understanding neutralising antibodies against SARS-CoV-2 and their implications in clinical practice. Mil Med Res. 2021;8(1):47. - PMC - PubMed
    1. Gupta SL, Jaiswal RK. Neutralizing antibody: a savior in the Covid-19 disease. Mol Biol Rep. 2022;49(3):2465–2474. doi: 10.1007/s11033-021-07020-6. - DOI - PMC - PubMed
    1. Ruggiero A, et al. SARS-CoV-2 vaccination elicits unconventional IgM specific responses in naïve and previously COVID-19-infected individuals. EBioMedicine. 2022;77:103888. doi: 10.1016/j.ebiom.2022.103888. - DOI - PMC - PubMed
    1. Dispinseri S, et al. Neutralizing antibody responses to SARS-CoV-2 in symptomatic COVID-19 is persistent and critical for survival. Nat Commun. 2021;12(1):2670. doi: 10.1038/s41467-021-22958-8. - DOI - PMC - PubMed
    1. Kaneko N, et al. Loss of Bcl-6-expressing T follicular helper cells and Germinal centers in COVID-19. Cell. 2020;183(1):143–157.e13. doi: 10.1016/j.cell.2020.08.025. - DOI - PMC - PubMed

Substances